Cisco Systems Inc vs Cassava Sciences Inc — how do they compare? Cisco Systems Inc trades at $123.05 (market cap $474.67B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Cisco Systems Inc is far larger — about 9940.7× Cassava Sciences Inc's market cap, and Cisco Systems Inc pays a 1.4% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| CSCO | FLNA | |
|---|---|---|
Market Cap | $474.67B | $47.75M |
Volume | 22,887,319 | — |
Sector | Technology | Health |
52-Week High | $130.00 | $4.64 |
52-Week Low | $66.20 | $0.87 |
Enterprise Value | $489.33B | -$34.93M |
Dividend Yield | 1.4% | — |
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $122.57, up 0.94% today, near its recent highs driven by strong AI cybersecurity momentum. The stock shows bullish technical signals with moving averages supporting the uptrend, while RSI levels indicate potential overbought conditions. Fundamentally, CSCO reported revenue of $56.65B in 2025 with a net income margin of 19.69%, and has beaten EPS estimates for three consecutive quarters. Recent news highlights partnerships and product launches in AI security, fueling investor optimism.
CSCO's outlook is positive with a consensus price target of $133.25, implying ~9% upside, supported by 52% analyst buy ratings. Key opportunities include growth in AI-driven networking and security demand, but risks involve high valuation multiples (P/E 40.14) and competitive pressures in the tech sector. Investors should weigh strong cash flow generation against execution risks in a dynamic market.
FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.
The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.
Trailing returns across standard periods
Latest headlines on both assets
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →